Treatment

Research Treatment

Exciting Preclinical Results About Vepafestinib

New published study with exciting preclinical results about the second generation RET inhibitor vepafestinib (TAS0953/HM06). Vepafestinib showed selectivity…

Irene Guijarro MunozOctober 10, 2023

Clinical Trials Treatment

New clinical trial testing amivantamab

New clinical trial testing amivantamab for patients who progressed on RET therapies: A Phase 1…

Irene Guijarro MunozOctober 8, 2023

Biomarker Testing Nino's News Treatment

Finding the Right Time to Ask About Biomarker Testing

Increasingly, cancer care is being approached with precision medicine methods that can offer personalized medical…

Irene Guijarro MunozJuly 27, 2023

Research Treatment

Two research studies funded by HLP presented at 2023 ASCO Mtg

Last week was the 2023 American Society of Clinical Oncology (ASCO) conference in Chicago. The…

Irene Guijarro MunozJune 19, 2023

Research Treatment

Ellipses Pharma presents ‘encouraging’ data on selective RET inhibitors

Data of the Phase 1 Study of KL590586 (EP0031/A400), presented at ASCO, reported preliminary efficacy…

Irene Guijarro MunozJune 19, 2023

Education Research Treatment

DAVA’s 2nd Hawaii Global Summit on Thoracic Malignancies

The DAVA’s 2nd Hawaii Global Summit on Thoracic Malignancies is a five-day meeting comprising seven…

Irene Guijarro MunozJune 19, 2023

Nino's News Treatment

Understanding the Role of a Care Team in Treatment Planning

When someone is diagnosed with cancer, it is critical that they and their caregivers take…

Irene Guijarro MunozApril 18, 2023

Education Treatment

Free Webinar: Testing and Targeting Tumors with RET Alterations

Watch this Free Webinar Series Testing and Targeting Tumors with RET Alterations The program is…

Irene Guijarro MunozNovember 22, 2022

Biomarker Testing Nino's News Treatment

The Importance of Biomarker Testing When Facing RET-Altered Cancers

Over the last decade and a half, there has been a rapid expansion of precision…

Irene Guijarro MunozSeptember 12, 2022

biopsy positive Non-Small Cell Adenocarcinoma

Stories Treatment

The Biopsy is positive for Non-Small Cell Adenocarcinoma

By Ilana Stromberg Co-Founder of The Happy Lungs Project Words so shocking that thoughts…

Irene Guijarro MunozAugust 6, 2021

Exciting Preclinical Results About Vepafestinib

New clinical trial testing amivantamab

Finding the Right Time to Ask About Biomarker Testing

Two research studies funded by HLP presented at 2023 ASCO Mtg

Ellipses Pharma presents ‘encouraging’ data on selective RET inhibitors

DAVA’s 2nd Hawaii Global Summit on Thoracic Malignancies

Understanding the Role of a Care Team in Treatment Planning

Free Webinar: Testing and Targeting Tumors with RET Alterations

The Importance of Biomarker Testing When Facing RET-Altered Cancers

The Biopsy is positive for Non-Small Cell Adenocarcinoma

Popular Posts

Scientific research can be confusing and overwhelming